Following Actimis Pharmaceuticals Inc.'s structured buyout deal last June, the San Diego-based firm's investors decided to back a spinout venture with the company's remaining assets, forming Axikin Pharmaceuticals Inc. (BioWorld Today)

Making health care more affordable, accessible, effective and safe, but less costly, for Americans has been an ongoing debate for decades, with little achieved over the many years of discussion. (BioWorld Financial Watch)